Research ArticleExperimental Studies

Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure

ESHAT F. HAQUE, RYOSUKE TANINO, TAMIO OKIMOTO, TAKAMASA HOTTA, TAKAE OKUNO, KENTO KONO, YUKARI TSUBATA and TAKESHI ISOBE
Anticancer Research March 2026, 46 (3) 1323-1335; DOI: https://doi.org/10.21873/anticanres.18032

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure
ESHAT F. HAQUE, RYOSUKE TANINO, TAMIO OKIMOTO, TAKAMASA HOTTA, TAKAE OKUNO, KENTO KONO, YUKARI TSUBATA, TAKESHI ISOBE
Anticancer Research Mar 2026, 46 (3) 1323-1335; DOI: 10.21873/anticanres.18032
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords